Key result
SGLT2 inhibitors induce proximal tubule fasting mimicry and rescue Srsf7 expression in diabetic kidney disease.
Answers are grounded in this paper and cite their sources.
Reveals distinct cell-type transcriptomic responses to therapies in murine diabetic kidney disease, implicating SGLT2 inhibitor regulation of proximal tubule alternative splicing.
Diabetic kidney disease (DKD) occurs in ∼40% of patients with diabetes and causes kidney failure, cardiovascular disease, and premature death. We analyzed the response of a murine DKD model to five treatment regimens using single-cell RNA sequencing (scRNA-seq). Our atlas of ∼1 million cells revealed a heterogeneous response of all kidney cell types both to DKD and its treatment. Both monotherapy and combination therapies targeted differing cell types and induced distinct and non-overlapping transcriptional changes. The early effects of sodium-glucose cotransporter-2 inhibitors (SGLT2i) on the S1 segment of the proximal tubule suggest that this drug class induces fasting mimicry and hypoxia responses. Diabetes downregulated the spliceosome regulator serine/arginine-rich splicing factor 7 (Srsf7) in proximal tubule that was specifically rescued by SGLT2i. In vitro proximal tubule knockdown of Srsf7 induced a pro-inflammatory phenotype, implicating alternative splicing as a driver of DKD and suggesting SGLT2i regulation of proximal tubule alternative splicing as a potential mechanism of action for this drug class.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2022) studied Murine diabetic kidney disease (DKD). Five DKD treatment regimens including sodium-glucose cotransporter-2 inhibitors (SGLT2i) monotherapy and combination therapies vs. Untreated murine diabetic kidney disease model and alternative monotherapy/combination regimens was evaluated on Single-cell transcriptomic response across kidney cell types, including Srsf7 expression in proximal tubule. SGLT2 inhibitors induced fasting mimicry and hypoxia responses in the S1 proximal tubule and specifically rescued Srsf7 downregulation across a ~1-million-cell murine DKD atlas.
Synapse has enriched 10 related papers. Consider them for comparative context: